[Skip to Content]
Sign In
Individual Sign In
Create an Account
Institutional Sign In
OpenAthens Shibboleth
[Skip to Content Landing]
Article
December 1989

Endotoxin Tolerance Is Associated With Reduced Secretion of Tumor Necrosis Factor

Author Affiliations

From the Department of Surgery, Division of Surgical Research, McGill University, Montreal, Canada.

Arch Surg. 1989;124(12):1432-1436. doi:10.1001/archsurg.1989.01410120082016
Abstract

• Bacterial endotoxin effects are partially mediated by tumor necrosis factor (TNF). It is known that sublethal doses of endotoxin induce transient refractoriness (tolerance) to some of its effects. We studied the role of TNF in endotoxin tolerance in rats. Weight loss, lethality, and TNF production were measured after an initial dose of endotoxin and after subsequent doses. Weight loss reached its peak 72 hours after the initial endotoxin challenge, followed by recovery even under continued administration of endotoxin. While tolerant, rats could survive a dose of endotoxin that was lethal for 100% of naive rats. The high serum levels of TNF, observed 90 minutes after the first dose of endotoxin, markedly diminished when rechallenged during tolerance. Recovery of responsiveness to these effects followed the refractory phase by 3 weeks. We concluded that endotoxin tolerance is associated with a reduced secretion of TNF.

(Arch Surg. 1989;124:1432-1436)

References
1.
McCabe WR, Kreger BE, Johns M.  Type-specific and cross-reactive antibodies in gram-negative bacteremia . N Engl J Med . 1972;287:261-267.Article
2.
Morrison DC, Ryan JL.  Endotoxins and disease mechanisms . Annu Rev Med . 1987;38:417-432.Article
3.
Natanson C, Eichenholtz PW, Danner RL, et al.  Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock . J Exp Med . 1989;169:823-832.Article
4.
Kirkland TN, Ziegler EJ.  An immunoprotective monoclonal antibody to lipopolysaccharide . J Immunol . 1984;132:2590-2592.
5.
Baumgartner JD, Glauser MP, McCutchan JA, et al.  Prevention of gramnegative shock and death in surgical patients by antibody to endotoxin core glycolipid . Lancet . 1985;2:59-63.Article
6.
Ziegler EJ, McCutchan JA, Fierre J, et al.  Treatment of gram-negative bacteremia and shock with human antiserum to a mutant Escherichia coli . N Engl J Med . 1982;307:1225-1230.Article
7.
Parrillo JE.  Septic shock: clinical manifestations, pathogenesis, hemodynamics, and management in a critical care unit . In: Parrillo JE, Ayres SM, eds. Major Issues in Critical Care Medicine . Baltimore, Md: Williams & Wilkins; 1984:111-125.
8.
Rietschel ET, Schade U, Jensen M, Wollenweber HW, Luderitz O, Greisman SG.  Bacterial endotoxins: chemical structure, biological activity and role in septicemia . Scand J Infect Dis Suppl . 1982;31:8-21.
9.
Beutler B.  Orchestration of septic shock by cytokines: the role of cachectin (tumor necrosis factor) . Prog Clin Biol Res . 1989;286:219-235.
10.
Beutler B, Milsark IW, Cerami AC.  Cachectin/tumor necrosis factor: production, distribution, and metabolic fate in vivo . J Immunol 1985;135:3972-3977.
11.
Tracey KJ, Beutler B, Lowry SF, et al.  Shock and tissue injury induced by recombinant human cachectin . Science . 1986;234:470-474.Article
12.
Tracey KJ, Lowry SF, Fahey TJ, et al.  Cachectin/tumor necrosis factor induces lethal shock and stress hormone responses in the dog . Surg Gynecol Obstet . 1987;164:415-422.
13.
Beutler B, Krochin N, Milsark IW, Luedke C, Cerami A.  Control of cachectin (tumor necrosis factor) synthesis: mechanisms of endotoxin resistance . Science . 1986;232:977-980.Article
14.
Beutler B, Milsark IW, Cerami AC.  Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin . Science . 1985;229:869-871.Article
15.
Tracey KJ, Fong Y, Hesse DG, et al.  Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia . Nature . 1987; 330:662-664.Article
16.
Beeson PB.  Tolerance to bacterial pyrogens, I: factors influencing its development . J Exp Med . 1947;86:29-44.Article
17.
Greisman SE, Hornick RB.  Endotoxin tolerance . In: Beers RF, Bassett EG, eds. The Role of Immunological Factors in Infectious, Allergic, and Autoimmune Processes . New York, NY: Raven Press; 1976:43-63.
18.
Lang CH, Spitzer JA.  Glucose kinetics and development of endotoxin tolerance during long-term continuous endotoxin infusion . Metabolism . 1987; 36:469-474.Article
19.
Fraker DL, Stovroff MC, Merino MJ, Norton JA.  Tolerance to tumor necrosis factor in rats and the relationship to endotoxin tolerance and toxicity . J Exp Med . 1988;168:95-105.Article
20.
Socher SH, Friedman A, Martinez D.  Recombinant human tumor necrosis factor induces acute reduction in food intake and body weight in mice . J Exp Med . 1988;167:1957-1962.Article
21.
Mossman T.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays . J Immunol Methods . 1983;65:55-63.Article
22.
Green LM, Reade JL, Ware CF.  Rapid colorimetric assay for cell viability: application to the quantitation of cytotoxic and growth inhibitory lymphokines . J Immunol Methods . 1984;70:257-268.Article
23.
 Alza Pharmaceuticals . Alzet Osmotic Pumps: Technical Applications File . Palo Alto, Calif: Alza Corp; 1986.
24.
Galanos C, Freudenberg MA, Matsura M, Coumbos A.  Hypersensitivity to endotoxin and mechanisms of host-response . Prog Clin Biol Res . 1989;272:295-308.
25.
Wallach D, Holtmann H, Engelmann H, Nophar Y.  Sensitization and desensitization to lethal effects of tumor necrosis factor and IL-1 . J Immunol . 1987;140:2994-2999.
26.
Vogel SN, Kaufman EN, Tate MD, Neta R.  Recombinant interleukin-1 alfa and recombinant tumor necrosis factor alfa synergize in vivo to induce early endotoxin tolerance and associated hematopoietic changes . Infect Immun . 1988;56:2650-2657.
27.
Madonna GS, Vogel SN.  Early endotoxin tolerance is associated with alterations in bone marrow-derived macrophage precursor pools . J Immunol . 1985;135:3763-3771.
28.
Rosenstreich DL, Vogel SN, Jacques AR, Wahl LM, Oppenheim JJ.  Macrophage sensitivity to endotoxin: genetic control by a single codominant gene . J Immunol . 1978;121:1664-1670.
29.
Apte RN, Ascher O, Pluznik DH.  Genetic analysis of generation of serum interferon by bacterial lipopolysaccharide . J Immunol . 1977;119:1898-1902.
30.
Vogel SN, Moore RN, Sipe JD, Rosenstreich DL.  BCG-induced enhancement of endotoxin sensitivity in C3H/HeJ mice, I: in vivo studies . J Immunol . 1980;124:2004-2009.
31.
Watson J, Kelly K, Largen M, Taylor BA.  The genetic mapping of a defective LPS response gene in C3H/HeJ mice . J Immunol . 1978;120:422-424.
×